Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.



In This Section

ACCC Joins in Letter to CMS Expressing Concerns with Proposed Part D & MA Rule

The Association of Community Cancer Centers (ACCC) joined more than 30 stakeholder organizations in a January 25 letter to the Centers for Medicare & Medicaid Services (CMS) outlining concerns over the impact of the administration's proposed rule on Modernizing Part D and Medicare Advantage. The letter addresses the following issues addressed in the proposed rule:
  • Providing plan flexibility to manage protected classes
  • Application of step therapy for Part D drugs by Medicare Advantage plans
  • Explanation of benefits requirements
  • Changes to the definition of negotiated price
  • Pharmacy price concessions in negotiated price.
Read the letter.

Posted 1/25/19